Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

WAY-169916

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A new method for the synthesis of 1H-indazoles from readily available N-tosylhydrazones and nitroaromatic compounds has been… Expand
  • figure 1
2012
2012
The bioactivities of the natural steroidal estrogen 17β-estradiol (E2), the synthetic estrogen diethylstilbestrol (DES), and the… Expand
Highly Cited
2010
Highly Cited
2010
The concept of selective receptor modulators has been established for the nuclear steroid hormone receptors. Such selective… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Highly Cited
2010
Highly Cited
2010
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mediates the toxicity of 2,3,7,8… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
2007
2007
Previous studies have shown that estrogen treatment protects the heart from reperfusion injury. The adverse effects of long-term… Expand
2006
2006
We previously reported on the development of a pathway-selective estrogen receptor (ER) ligand, WAY-169916, that has ER-dependent… Expand
2005
2005
  • J. Owens
  • Nature Reviews Drug Discovery
  • 2005
  • Corpus ID: 38990431
A compound that acts via the oestrogen receptor (ER) to selectively inhibit nuclear factor-κB (NF-κB) without displaying… Expand
2005
2005
A compound that acts via the oestrogen receptor (ER) to selectively inhibit nuclear factor-κB (NF-κB) without displaying… Expand